ARTICLE | Company News
Antex, BioPort deal
March 24, 2003 8:00 AM UTC
Anthrax vaccine manufacturer BioPort will acquire ANX for $3 million in cash or $3.6 million in cash and notes. ANX develops products to prevent and treat infections and related diseases. Additionally...